Template:Pico of the day/2013-08-22

From Wiki Journal Club
Jump to navigation Jump to search
Clinical question of the day
Among patients with advanced HER2-positive breast cancer previously treated with trastuzumab and a taxane, does trastuzumab-emtansine prolong PFS and OS when compared to lapatanib+capecitabine?